Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis

Archives of General Psychiatry

Volumn 66, Issue 4, 2009, Pages 366-376

  Takahashi, Tsutomu ^a   Wood, Stephen J ^a   Yung, Alison R ^a   Soulsby, Bridget ^a   McGorry, Patrick D ^a   Suzuki, Michio ^a   Kawasaki, Yasuhiro ^a   Phillips, Lisa J ^a   Velakoulis, Dennis ^a   Pantelis, Christos ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAIN REGION; BRAIN SIZE; CINGULATE GYRUS; CLINICAL FEATURE; CONTROLLED STUDY; DELUSION; DISEASE SEVERITY; FEMALE; FOLLOW UP; FRONTAL CORTEX; GRAY MATTER; HIGH RISK PATIENT; HUMAN; LEFT HEMISPHERE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; ATROPHY; BIPOLAR DISORDER; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; CROSS-SECTIONAL STUDIES; DELUSIONS; DEPRESSIVE DISORDER, MAJOR; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; PSYCHOTIC DISORDERS; RISK FACTORS; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SCHIZOTYPAL PERSONALITY DISORDER; SEX FACTORS; TEMPORAL LOBE; YOUNG ADULT;

EID: 64849086184     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2009.12     Document Type: Article

References (84)

1. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987;44(7):660-669.
2. Cannon TD, van Erp TG, Bearden CE, Loewy R, Thompson P, Toga AW, Huttunen MO, Keshavan MS, Seidman LJ, Tsuang MT. Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions. Schizophr Bull. 2003;29(4): 653-669.
3. Pantelis C, Velakoulis D, Wood SJ, Yücel M, Yung AR, Phillips LJ, Sun DQ, McGorry PD. Neuroimaging and emerging psychotic disorders: the Melbourne ultra-high risk studies. Int Rev Psychiatry. 2007;19(4):371-381.
4. Pantelis C, Yucel M, Wood SJ, Velakoulis D, Sun D, Berger G, Stuart GW, Yung A, Phillips L, McGorry PD. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr Bull. 2005;31(3):672-696.
5. Wood SJ, Pantelis C, Velakoulis D, Yucel M, Fornito A, McGorry PD. Progressive changes in the development toward schizophrenia: studies in subjects at increased symptomatic risk. Schizophr Bull. 2008;34(2):322-329.
6. Gur RE, Cowell P, Turetsky BI, Gallacher F, Cannon T, Bilker W, Gur RC. A follow-up magnetic resonance imaging study of schizophrenia: relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry. 1998;55(2):145-152.
7. Ho BC, Andreasen NC, Nopoulos P, Arndt S, Magnotta V, Flaum M. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry. 2003;60(6):585-594.
8. Kasai K, Shenton ME, Salisbury DF, Hirayasu Y, Lee CU, Ciszewski AA, Yurgelun- Todd D, Kikinis R, Jolesz FA, McCarley RW. Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia. Am J Psychiatry. 2003;160(1):156-164.
9. Kasai K, Shenton ME, Salisbury DF, Hirayasu Y, Onitsuka T, Spencer MH, Yurgelun- Todd DA, Kikinis R, Jolesz FA, McCarley RW. Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry. 2003; 60(8):766-775.
10. Sun D, Stuart GW, Jenkinson M, Wood SJ, McGorry PD, Velakoulis D, van Erp TG, Thompson PM, Toga AW, Smith DJ, Cannon TD, Pantelis C. Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study [published online July 8, 2008]. Mol Psychiatry. doi:10.1038/mp.2008.34.
11. Wood SJ, Velakoulis D, Smith DJ, Bond D, Stuart GW, McGorry PD, Brewer WJ, Bridle N, Eritaia J, Desmond P, Singh B, Copolov D, Pantelis C. A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia. Schizophr Res. 2001;52(1-2):37-46.
12. Job DE, Whalley HC, Johnstone EC, Lawrie SM. Grey matter changes over time in high risk subjects developing schizophrenia. Neuroimage. 2005;25 (4):1023-1030.
13. Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ, Yung AR, Bullmore ET, Brewer W, Soulsby B, Desmond P, McGuire PK. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet. 2003;361(9354):281-288.
14. Sun D, Phillips L, Velakoulis D, Yung A, McGorry PD, Wood SJ, van Erp TG, Thompson PM, Toga AW, Cannon TD, Pantelis C. Progressive brain structural changes mapped as psychosis develops in "at risk" individuals (abstract). Schizophr Bull. 2007;33(2):356-357.
15. Walterfang M, McGuire PK, Yung A, Phillips LJ, Velakoulis D, Wood SJ, Suckling J, Bullmore ET, Brewer W, Soulsby B, Desmond P, McGorry PD, Pantelis C. White matter volume changes in people who develop psychosis. Br J Psychiatry. 2008;193(3):210-215.
16. Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, McGorry PD. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr Res. 2003;60(1):21-32.
17. Yung AR, Phillips LJ, Yuen HP, McGorry PD. Risk factors for psychosis in an ultra high-risk group. Schizophr Res. 2004;67(2-3):131-142.
18. Johnstone EC, Abukmeil SS, Byrne M, Clafferty R, Grant E, Hodges A, Lawrie SM, Owens DG. Edinburgh High Risk Study-findings after four years: demographic, attainment and psychopathological issues. Schizophr Res. 2000;46(1):1-15.
19. Giuliani NR, Calhoun VD, Pearlson GD, Francis A, Buchanan RW. Voxel-based morphometry versus region of interest. Schizophr Res. 2005;74(2-3):135-147.
20. Thompson PM, Giedd JN, Woods RP, MacDonald D, Evans AC, Toga AW. Growth patterns in the developing brain detected by using continuum mechanical tensor maps. Nature. 2000;404(6774):190-193.
21. Honea R, Crow TJ, Passingham D, Mackay CE. Regional deficits in brain volume in schizophrenia. Am J Psychiatry. 2005;162(12):2233-2245.
22. Shenton ME, Dickey CC, Frumin M, McCarley RW. A review of MRI findings in schizophrenia. Schizophr Res. 2001;49(1-2):1-52.
23. Suzuki M, Nohara S, Hagino H, Kurokawa K, Yotsutsuji T, Kawasaki Y, Takahashi T, Matsui M, Watanabe N, Seto H, Kurachi M. Regional changes in brain gray and white matter in patients with schizophrenia demonstrated with voxel-based analysis of MRI. Schizophr Res. 2002;55(1-2):41-54.
24. Hirayasu Y, McCarley RW, Salisbury DF, Tanaka S, Kwon JS, Frumin M, Snyderman D, Yurgelun-Todd D, Kikinis R, Jolesz FA, Shenton ME. Planum temporale and Heschl gyrus volume reduction in schizophrenia: a magnetic resonance imaging study of first-episode patients. Arch Gen Psychiatry. 2000;57(7):692-699.
25. Rojas DC, Teale P, Sheeder J, Simon J, Reite M. Sex-specific expression of Heschl's gyrus functional and structural abnormalities in paranoid schizophrenia. Am J Psychiatry. 1997;154(12):1655-1662.
26. Takahashi T, Suzuki M, Zhou SY, Tanino R, Hagino H, Kawasaki Y, Matsui M, Seto H, Kurachi M. Morphologic alterations of the parcellated superior temporal gyrus in schizophrenia spectrum. Schizophr Res. 2006;83(2-3):131-143.
27. Kwon JS, McCarley RW, Hirayasu Y, Anderson JE, Fischer IA, Kikinis R, Jolesz FA, Shenton ME. Left planum temporale volume reduction in schizophrenia. Arch Gen Psychiatry. 1999;56(2):142-148.
28. Sumich A, Chitnis XA, Fannon DG, O'Ceallaigh S, Doku VC, Falrowicz A, Marshall N, Matthew VM, Potter M, Sharma T. Temporal lobe abnormalities in firstepisode psychosis. Am J Psychiatry. 2002;159(7):1232-1235.
29. Yamasue H, Yamada H, Yumoto M, Kamio S, Kudo N, Uetsuki M, Abe O, Fukuda R, Aoki S, Ohtomo K, Iwanami A, Kato N, Kasai K. Abnormal association between reduced magnetic mismatch field to speech sounds and smaller left planum temporale volume in schizophrenia. Neuroimage. 2004;22(2):720-727.
30. Pearlson GD. Superior temporal gyrus and planum temporale in schizophrenia: a selective review. Prog Neuropsychopharmacol Biol Psychiatry. 1997;21(8):1203- 1229.
31. Barta PE, Pearlson GD, Powers RE, Richards SS, Tune LE. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am J Psychiatry. 1990;147(11):1457-1462.
32. Shenton ME, Kikinis R, Jolesz FA, Pollak SD, LeMay M, Wible CG, Hokama H, Martin J, Metcalf D, Coleman M, McCarley RW. Abnormalities of the left temporal lobe and thought disorder in schizophrenia: a quantitative magnetic resonance imaging study. N Engl J Med. 1992;327(9):604-612.
33. Sumich A, Chitnis XA, Fannon DG, O'Ceallaigh S, Doku VC, Faldrowicz A, Sharma T. Unreality symptoms and volumetric measures of Heschl's gyrus and planum temporal in first-episode psychosis. Biol Psychiatry. 2005;57(8): 947-950.
34. Rajarethinam RP, DeQuardo JR, Nalepa R, Tandon R. Superior temporal gyrus in schizophrenia. Schizophr Res. 2000;41(2):303-312.
35. Price C. An overview of speech comprehension and production. In: Frackowiak RSJ, Friston KJ, Frith CD, Dolan RJ, Price CJ, eds. Human Brain Function. 2nd ed. San Diego, CA: Elsevier Academic Press; 2004:517-545.
36. Gallagher HL, Frith CD. Functional imaging of "theory of mind." Trends Cogn Sci. 2003;7(2):77-83.
37. Salisbury DF, Kuroki N, Kasai K, Shenton ME, McCarley RW. Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Arch Gen Psychiatry. 2007;64(5):521-529.
38. Borgwardt SJ, Riecher-Rossler A, Dazzan P, Chitnis X, Aston J, Drewe M, Gschwandtner U, Haller S, Pflüger M, Rechsteiner E, D'Souza M, Stieglitz RD, Radü EW, McGuire PK. Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatry. 2007;61(10):1148-1156.
39. Rajarethinam R, Sahni S, Rosenberg DR, Keshavan MS. Reduced superior temporal gyrus volume in young offspring of patients with schizophrenia. Am J Psychiatry. 2004;161(6):1121-1124.
40. Keshavan MS, Haas GL, Kahn CE, Aguilar E, Dick EL, Schooler NR, Sweeney JA, Pettegrew JW. Superior temporal gyrus and the course of early schizophrenia: progressive, static, or reversible? J Psychiatr Res. 1998;32(3-4): 161-167.
41. Takahashi T, Suzuki M, Tanino R, Zhou SY, Hagino H, Niu L, Kawasaki Y, Seto H, Kurachi M. Volume reduction of the left planum temporale gray matter associated with long duration of untreated psychosis in schizophrenia: a preliminary report. Psychiatry Res. 2007;154(3):209-219.
42. McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, Germano D, Bravin J, McDonald T, Blair A, Adlard S, Jackson H. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry. 2002; 59(10):921-928.
43. Rhoades HM, Overall JE. The semistructured BPRS interview and rating guide. Psychopharmacol Bull. 1988;24(1):101-104.
44. Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS). Iowa City: University of Iowa; 1983.
45. Yung AR, Phillips LJ, McGorry PD. Treating Schizophrenia in the Prodromal Phase. London, England: Taylor & Francis; 2004.
46. McGorry PD, Edwards J, Mihalopoulos C, Harrigan SM, Jackson HJ. EPPIC: an evolving system of early detection and optimal management. Schizophr Bull. 1996;22(2):305-326.
47. Velakoulis D, Pantelis C, McGorry PD, Dudgeon P, Brewer W, Cook M, Desmond P, Bridle N, Tierney P, Murrie V, Singh B, Copolov D. Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study. Arch Gen Psychiatry. 1999;56(2):133-141.
48. First MB, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for DSM-IV Axis I Disorders. Washington, DC: American Psychiatric Press; 1997.
49. McGorry PD, Kaplan I, Dossetor C, Herrman H, Copolov D, Singh B. Royal Park Multidiagnostic Instrument for Psychosis. Melbourne, Australia: National Health and Medical Research Council; 1989.
50. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-276.
51. Nelson HE, O'Connell A. Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test. Cortex. 1978;14(2):234-244.
52. American Psychiatric Association. Diagnostic Criteria From DSM-IV. Washington, DC: American Psychiatric Association; 1994.
53. Alpert NM, Berdichevsky D, Levin Z, Morris ED, Fischman AJ. Improved methods for image registration. Neuroimage. 1996;3(1):10-18.
54. Takahashi T, Kawasaki Y, Kurokawa K, Hagino H, Nohara S, Yamashita I, Nakamura K, Murata M, Matsui M, Suzuki M, Seto H, Kurachi M. Lack of normal structural asymmetry of the anterior cingulate gyrus in female patients with schizophrenia. Schizophr Res. 2002;55(1-2):69-81.
55. Eritaia J, Wood SJ, Stuart GW, Bridle N, Dudgeon P, Maruff P, Velakoulis D, Pantelis C. An optimized method for estimating intracranial volume from magnetic resonance images. Magn Reson Med. 2000;44(6):973-977.
56. Velakoulis D, Wood SJ, Wong MT, McGorry PD, Yung A, Phillips L, Smith D, Brewer W, Proffitt T, Desmond P, Pantelis C. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch Gen Psychiatry. 2006;63(2):139-149.
57. Kim JJ, Crespo-Facorro B, Andreasen NC, O'Leary DS, Zhang B, Harris G, Magnotta VA. An MRI-based parcellation method for the temporal lobe. Neuroimage. 2000;11(4):271-288.
58. McGlashan TH. Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course? Biol Psychiatry. 1999;46(7):899-907.
59. Crow TJ. Nature of the genetic contribution to psychotic illness: a continuum viewpoint. Acta Psychiatr Scand. 1990;81(5):401-408.
60. Maier W, Zobel A, Wagner M. Schizophrenia and bipolar disorder: differences and overlaps. Curr Opin Psychiatry. 2006;19(2):165-170.
61. Murray RM, Sham P, Van Os J, Zanelli J, Cannon M, McDonald C. A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr Res. 2004;71(2-3):405-416.
62. Weinberger DR, McClure RK. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? Arch Gen Psychiatry. 2002;59(6):553-558.
63. van Haren NE, Hulshoff Pol HE, Schnack HG, Cahn W, Brans R, Carati I, Rais M, Kahn RS. Progressive brain volume loss in schizophrenia over the course of the illness. Biol Psychiatry. 2008;63(1):106-113.
64. Mathalon DH, Sullivan EV, Lim KO, Pfefferbaum A. Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry. 2001;58(2): 148-157.
65. Johnstone EC, Ebmeier KP, Miller P, Owens DG, Lawrie SM. Predicting schizophrenia. Br J Psychiatry. 2005;186:18-25.
66. McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging of psychiatric disorders. Aust N Z J Psychiatry. 2006;40(8):616-622.
67. Cahn W, Hulshoff Pol HE, Lems EB, van Haren NE, Schnack HG, van der Linden JA, Schothorst PF, van Engeland H, Kahn RS. Brain volume changes in firstepisode schizophrenia. Arch Gen Psychiatry. 2002;59(11):1002-1010.
68. Nakamura M, Salisbury DF, Hirayasu Y, Bouix S, Pohl KM, Yoshida T, Koo MS, Shenton ME, McCarley RW. Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study. Biol Psychiatry. 2007;62(7):773-783.
69. van Haren NE, Cahn W, Hulshoff Pol HE, Schnack HG, Caspers E, Lemstra A, Sitskoorn MM, Wiersma D, van den Bosch RJ, Dingemans PM, Schene AH, Kahn RS. Brain volumes as predictor of outcome in recent-onset schizophrenia: a multicenter MRI study. Schizophr Res. 2003;64(1):41-52.
70. Sweet RA, Pierri JN, Auh S, Sampson AR, Lewis DA. Reduced pyramidal cell somal volume in auditory association cortex of subjects with schizophrenia. Neuropsychopharmacology. 2003;28(3):599-609.
71. Cotter D, Mackay D, Frangou S, Hudson L, Landau S. Cell density and cortical thickness in Heschl's gyrus in schizophrenia, major depression and bipolar disorder. Br J Psychiatry. 2004;185:258-259.
72. Beasley CL, Chana G, Honavar M, Landau S, Everall IP, Cotter D. Evidence for altered neuronal organisation within the planum temporale in major psychiatric disorders. Schizophr Res. 2005;73(1):69-78.
73. Coyle JT, Tsai G, Goff D. Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann N Y Acad Sci. 2003;1003:318- 327.
74. Stone JM, Morrison PD, Pilowsky LS. Glutamate and dopamine dysregulation in schizophrenia. J Psychopharmacol. 2007;21(4):440-452.
75. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry. 2005;62(9):975-983.
76. Perkins DO, Gu H, Boteva K, Lieberman JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry. 2005;162(10):1785-1804.
77. Schmitz N, Malla A, Norman R, Archie S, Zipursky R. Inconsistency in the relationship between duration of untreated psychosis (DUP) and negative symptoms: sorting out the problem of heterogeneity. Schizophr Res. 2007;93(1-3):152-159.
78. Dazzan P, Morgan KD, Orr K, Hutchinson G, Chitnis X, Suckling J, Fearon P, McGuire PK, Mallett RM, Jones PB, Leff J, Murray RM. Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology. 2005;30(4):765-774.
79. Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, Keefe RS, Green AI, Gur RE, McEvoy J, Perkins D, Hamer RM, Gu H, Tohen M; HGDH Study Group. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry. 2005;62(4):361-370.
80. Molina V, Reig S, Sanz J, Palomo T, Benito C, Sánchez J, Sarramea F, Pascau J, Desco M. Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia. Schizophr Res. 2005;80(1):61-71.
81. McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW, Hawkins KA, Hoffman RE, Preda A, Epstein I, Addington D, Lindborg S, Trzaskoma Q, Tohen M, Breier A. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry. 2006; 163(5):790-799.
82. Gogtay N, Greenstein D, Lenane M, Clasen L, Sharp W, Gochman P, Butler P, Evans A, Rapoport J. Cortical brain development in nonpsychotic siblings of patients with childhood-onset schizophrenia. Arch Gen Psychiatry. 2007;64(7): 772-780.
83. Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK, Manji HK. Lithium-induced increase in human brain grey matter [published correction appears in Lancet. 2000;356(9247):2104]. Lancet. 2000;356(9237):1241-1242.
84. Crum WR, Griffin LD, Hill DL, Hawkes DJ. Zen and the art of medical image registration: correspondence, homology, and quality. Neuroimage. 2003;20(3): 1425-1437.